The SITC Immune Monitor
November 2013

President's Message

Dear Colleagues,

I hope you are as excited as I am for the SITC 28th Annual Meeting & Associated Programs – beginning in just a few short days on Thursday, November 7! While online registration is now closed, you can still register for any part of the meeting on-site at the Gaylord National Hotel and Convention Center, beginning at 5:00 pm EST on Wednesday, November 6.

Registration for SITC 2013 has already reached record numbers and I am looking forward to having more than 900 domestic and international basic, clinical, and translational scientists from academia, government, and the biotech/pharmaceutical industry altogether for three-days of cutting-edge research presentations, education and networking.

Beyond SITC 2013, I also wanted to remind you of our “Advances in Cancer Immunotherapy” regional, CME-certified programs coming up this December. More information on these programs can be found below, along with other upcoming Society programs in Italy, Qatar and Germany.

As always, thank you for your support of SITC and the work you are doing to help us advance the science and application of cancer immunotherapy. Together we can continue to drive the field forward and elevate cancer immunotherapy as a fourth standard of care for cancer patients everywhere. I hope to see you at SITC 2013!

Sincerely,


Francesco Marincola, MD
SITC President


SITC 28th Annual Meeting & Associated Programs Begin this Week!

November 7-10, 2013 • Gaylord National Hotel and Convention Center • National Harbor, MD

SITC 2013 will be a record-breaking year with more than 900 of the brightest minds coming together from the cancer immunotherapy community. SITC sets itself apart from other meetings with a family-like feel that brings together all areas of the field including domestic and international basic, clinical, and translational scientists from academia, government, and the biotech/pharmaceutical industry.

Online registration is now closed, but on-site registration can be completed at the Gaylord National Hotel and Convention Center beginning Wednesday, November 6 from 5:00 - 8:00 pm EST.

For more information on SITC 2013 as well as travel and transportation information please visit: www.sitcancer.org/2013/home/travel.

Calling all Clinical Oncologists -
Register Now for Regional, CME- Certified "Advances in Cancer Immunotherapy" Programs

Earn CME-credits before the end of the year by attending one of SITC's regional "Advances in Cancer Immunotherapy" programs. Specifically designed for clinical oncologists and the entire unit of care involved in treating cancer patients with immunotherapy, these programs discuss basic immunology principles underlying the clinical application of immunotherapy and summarize central themes in research advances and approvals to:

  • Facilitate understanding of more sophisticated principles of tumor immunology and immunotherapy
  • Promote appropriate clinical application of cancer immunotherapies, how they work, their side effects and efficacy to improve cancer patient outcomes

To register for any of these programs and for more information, visit: www.sitcancer.org/sitc-meetings/aci2013.

Registration Now Open!
Updates on Immunotherapy of Cancer and Immunoscore

Part of the Sidra Symposia Series, Held in Partnership with the Society for Immunotherapy of Cancer

January 22-23, 2014 • St. Regis Doha • Doha, Qatar

This symposium is focused on improving the outcome for patients with cancer by incorporating strategies based on cancer immunotherapy. With leading authorities in tumor immunology and cancer immunotherapy, this program will describe the latest research advances, focus on currently approved and emerging tumor immunotherapy approaches and provide highlights on SITC initiatives and projects including the Immunoscore.

To register and for more information please visit: www.sitcancer.org/sitc-meetings/sidrasymposium.

SITC Continues Partnership at Melanoma Bridge 2013

December 5-8, 2013 • Royal Continental Hotel • Naples, Italy

Melanoma Bridge 2013 is jointly organized by SITC, Istituto Nazionale Tumori Fondazione "G. Pascale,” Sidra Medical and Research Center, and Fondazione Melanoma Onlus and aims to achieve a broad-based participation by various groups and societies sharing a clinical or basic interest in the immunology and biology of the cancer microenvironment.

The meeting will consist of the following sections:

  • Diagnosis and new procedures
  • Molecular advances and combination therapies
  • News in Immunotherapy
  • Tumor microenvironment and biomarkers
  • World-Wide SITC Immunoscore Task Force update
  • Round Table of US and EU Regulatory Agency on Melanoma drugs.

For more information visit: www.sitcancer.org/sitc-meetings/melanoma-bridge-2013.

SITC Joins BDA and Others for 1st European Immunotherapy of Cancer Conference

March 12-14, 2014 • Munich, Germany

As the first European Cancer Immunotherapy meeting, the goal of this conference is to provide a forum for discussion on early clinical drug development and address the unique challenges involved. The program will focus on topics such as immunomodulatory agents, anti-cancer vaccines and monoclonal antibodies with special emphasis on translational research and biomarker development. Organized by the Biotherapy Development Association (BDA), partners include SITC, Comprehensive Cancer Center of the Ludwig-Maximilians-Universitat Munchen (CCCLMU), Roman-Herzog-Krebszentrum Comprehensive Cancer Center (RHCCC) and Munich Tumor Center (TZM).

For more information, visit: www.sitcancer.org/sitc-meetings/itoc2014.

 

 

Advertisement